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Bioresponsive hydrogels
We highlight recent developments in hydrogel materials with biological 
responsiveness built in. These ‘smart’ biomaterials change properties in 
response to selective biological recognition events. When exposed to a 
biological target (nutrient, growth factor, receptor, antibody, enzyme, or 
whole cell), molecular recognition events trigger changes in molecular 
interactions that translate into macroscopic responses, such as 
swelling/collapse or solution-to-gel transitions. The hydrogel transitions 
may be used directly as optical readouts for biosensing, linked to the 
release of actives for drug delivery, or instigate biochemical signaling 
events that control or direct cellular behavior. Accordingly, bioresponsive 
hydrogels have gained significant interest for application in diagnostics, 
drug delivery, and tissue regeneration/wound healing. 
Rein V. Ulijn*, Nurguse Bibi, Vineetha Jayawarna, Paul D. Thornton, Simon J. Todd, Robert J. Mart, Andrew M. Smith, and 
Julie E. Gough 
School of Materials and Manchester Interdisciplinary Biocentre (MIB), Grosvenor Street, Manchester, M1 7HS, UK 
*E-mail: rein.ulijn@manchester.ac.uk
Modern biomaterials are increasingly designed to interface 
with biological tissues in predefined ways. An important class 
of biomaterials are those that are highly hydrated – hydrogels. 
Hydrogels consist of elastic networks with interstitial spaces that 
contain as much as 90-99% w/w water1,2. They are prepared by 
chemical polymerization or by physical self-assembly of man-
made or naturally occurring building blocks. Most commonly, 
these building blocks are macromolecules in a variety of 
architectures, including cross-linked polymers2, entangled fibrillar 
networks3,4, or colloidal assemblies5-8. Recently, small amphiphilic 
molecules have emerged as a new class of hydrogelators, forming 
supramolecular or molecular hydrogels9-11.
Hydrogel materials are increasingly studied for applications in biological 
sensing, drug delivery, and tissue regeneration for a number of reasons:
• Hydrogels provide suitable semiwet, three-dimensional 
environments for molecular-level biological interactions12-15;
• Many hydrogels provide inert surfaces that prevent nonspecific 
adsorption of proteins, a property known as antifouling;
• Biological molecules can be covalently incorporated into hydrogel 
structures using a range of well-established chemistries14;
• Hydrogel mechanical properties are highly tunable, for example 
elasticity can be tailored by modifying cross-link densities; and
• Hydrogels can be designed to change properties (e.g. swelling/
collapse or solution-to-gel transitions) in response to externally 
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applied triggers, such as temperature, ionic strength, solvent 
polarity, electric/magnetic field, light, or small (bio)molecules16-21.
In this review, we focus on responsive hydrogel materials that 
have been designed to engage in a dialogue with their biological 
environment22-25. Material-to-biology communication, whereby a 
biological event occurs upon interaction with the material, can be 
achieved by introducing ligands that bind specific biomolecules into 
the material structure. These ligands provide instructions to control or 
direct biological interactions. 
In tissue regeneration, biomaterials may be designed to contain 
precisely positioned bioactive ligands that instruct cell behavior. A well-
known example is the cell-adhesive tripeptide, Arg-Gly-Asp (RGD). This 
peptide is derived from fibronectin, a component of the extracellular 
matrix (ECM) to which cells attach in vivo. Incorporation of RGD into 
hydrogel structures instructs many cell types to attach to the material 
via cell-surface proteins called integrins26,27. Another example is the 
laminin-derived peptide Ile-Lys-Val-Ala-Val (IKVAV), which can be 
incorporated into a hydrogel to trigger stem cell differentiation toward 
neuronal cells28. As well as peptides, polysaccharides may also be used 
as bioactive ligands to direct cell behavior. For example, Ranjangam 
et al.29 have incorporated heparin into peptide amphiphile assemblies 
to control angiogenesis (new blood vessel formation). Biomaterials that 
contain biological instructions have been around since the 1980s and 
are often termed bioactive (Fig. 1, top) .
A relatively new concept is the incorporation of biology-to-material 
interactions into hydrogels, whereby biomolecules or cells trigger 
macroscopic transitions22,23,25,30. These bioresponsive or biointeractive 
materials contain receptors for biomolecules that, when stimulated, 
cause localized or bulk changes in the material properties. This is of 
special interest in developing autonomous systems that can detect 
disease markers and respond to them to repair the diseased area25.
Three types of stimuli for bioresponsive hydrogel systems can be 
distinguished. First, hydrogel materials can be modified to contain small 
biomolecules that selectively bind to biomacromolecules, including 
protein receptors or antibodies. Upon binding, a macroscopic transition 
follows (Fig. 1, system I). Second, systems may be modified with 
enzyme-sensitive substrates, such as short peptides (Fig. 1, system II). 
Here, the initial molecular recognition event is similar to that in the 
first category (enzyme protein binds to substrate), but it is followed 
by a chemical event involving the making or breaking of bonds within 
the enzyme-sensitive substrate. Since enzymes are highly selective, 
materials can be programmed to respond to a specific enzyme by 
incorporation of the specific substrate (or a substrate mimic). This 
concept is especially attractive because the distribution of enzymes can 
differ between healthy and diseased cells, between different cell types, 
and during cellular migration, differentiation, and cell division31,32. 
Third, systems may have biomacromolecules, such as enzymes, 
incorporated into their structures that recognize small biomolecules 
(Fig. 1, system III). Enzymatic conversion of these biomolecules into 
molecules with different physical properties (e.g. an acid or basic 
compound) then triggers hydrogel swelling or collapse.
Bioresponsive hydrogels for drug delivery 
Much work on bioresponsive hydrogels for drug delivery relates to 
the release of insulin in response to raised blood sugar levels as a 
potential autonomous treatment of insulin-dependant diabetes33-35. 
In one approach, glucose oxidase molecules are immobilized onto a 
basic polymeric carrier34. Following the enzyme reaction that converts 
glucose to gluconic acid, thereby temporarily lowering the pH, the basic 
groups on the polymer are protonated, inducing swelling and enhancing 
the release profile of insulin (Table 1, entry 1) 33,34. This system works 
as a feedback loop: upon release of insulin the sugar levels drop, 
resulting in a pH increase that stops the release of further insulin. 
More recently, glucose oxidase has been employed in an oxidation-
state responsive system based on polysulfide nanoparticles modified 
with biocompatible polymer chains known as pluronics (block 
copolymers of hydroxyl-terminated propylene and ethylene oxides). 
Enzyme action triggers the oxidation of sulfides in the presence of 
glucose, causing nanoparticle swelling and eventually the release of 
encapsulated molecules in a manner proportional to the extent of 
oxidation (Table 1, entry 2)35. This type of response is of importance in 
targeted drug delivery to inflammation sites and certain tumors where 
enhanced concentrations of oxidizing species are found24,36.
An important aim in targeted drug delivery is to develop systems 
that carry a drug to the site where it is needed before releasing it. 
This approach37, originally suggested in 1975, allows for maximum 
drug absorption at the disease site while simultaneously minimizing 
premature metabolism and excessive background levels of drugs that 
Fig. 1 Bioactive hydrogel (top) and three different types of bioresponsive 
hydrogel (bottom) that change properties in response to (i) small molecules 
via receptor/ligand interactions; (ii) (cell-secreted) enzymes via cleavable 
linkers; and (iii) small molecules that are converted by immobilized enzymes. 
The macroscopic response (swelling/collapse of the hydrogel) is shown.
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may be toxic. Emerging therapies for site-specific release exploit the 
catalytic action of disease-specific enzymes to trigger drug release 
from polymeric prodrug carriers. Prodrugs are inactive precursors of 
drug molecules that are activated in vivo, usually through enzymatic 
hydrolysis. For example, a cancer-specific enzyme secreted by tumor 
cells can be used to trigger the release of a therapeutic agent to 
prevent or reduce metastasis (targeted chemotherapy). This objective 
may be achieved by immobilizing drug molecules linked to a polymeric 
backbone (such as polyethylene glycol, or PEG) via enzyme-cleavable 
linkers30,38,39. In addition, several strategies have been devised 
that use a range of stimuli-responsive molecular and polymeric 
carrier molecules17,18,40. In some systems, both of these concepts 
are combined, i.e. exploiting biological events as triggers to induce 
macroscopic transitions in hydrogel materials that release the payload. 
A procedure for two-step mediated drug release has been 
developed42. Here, a drug mimic is incorporated into gel fibers where 
the enzyme cannot act because of limited access to enzyme-cleavable 
linkers within the fibrillar network. Upon application of temperature or 
pH, the fibers dissociate, greatly accelerating the rate of hydrolysis and 
consequent release of the drug mimic (Table 1, entry 3). 
Lee et al.43 have demonstrated a carrier-drug conjugate that is 
cleaved by penicillin G amidase (PGA) from E. coli cells containing the 
PGA gene. The release of the drug molecule and a fluorescent probe 
is observed when the carrier is incubated in E. coli containing the PGA 
gene. Release is not observed when the PGA gene is absent. The carrier 
lowers the levels of drug required to kill the bacteria in addition to 
providing a route for targeted combination therapy (Table 1, entry 4). 
In addition to the conjugate and prodrug methods where drug 
molecules are chemically incorporated into the hydrogel, there are 
examples of drug delivery via enzyme-triggered gel dissolution. Such 
systems deliver physically entrapped guest molecules, held freely 
within the carrier, and do not require chemical modification for 
targeted delivery. Using dissolving gels allows a variable volume 
of drug to be released that is no longer directly linked to enzyme 
catalysis. Instead, the pharmacokinetics of the system can be tuned by 
polymer design. Li et al.44 have produced a biochemically and stimulus 
responsive triblock copolymer. The polymer forms a micellar, dithiol 
cross-linked N-isopropylacrylamide (NIPAm) gel at 37°C that can be 
degraded by glutathione via cleavage of a central disulfide bond 
(Fig. 2) . Thus, the system offers the possibility of payload release from 
a loaded gel following glutathione-stimulated degradation (Table 1, 
entry 5). 
Plunkett et al.45 have developed a protocol to synthesize hydrogels 
with cross-links composed of different enzyme-cleavable peptides. 
Chymotrypsin hydrolyzes a Cys-Tyr-Lys-Cys tetrapeptide cross-link, 
causing degradation of the gel, but has no effect on a Cys-Ser-Lys-
Cys cross-link (Table 1, entry 6). Law et al.46 have reported nontoxic 
peptide-based matrices that degrade following enzyme reaction. The 
core peptide sequence consists of a protease-cleavable region flanked 
by two self-assembly motifs. Successful enzyme cleavage results in 
Fig. 2 (a) Biochemical degradation of a micellar, dithiol cross-linked NIPAm gel in the presence of glutathione. (b) Viscometry data showing the transition between 
these phases. (Adapted and reprinted with permission from44. © 2006 Wiley-VCH.)
Entry Hydrogel Stimulus Mode of release
1 Ethylene/vinyl acetate29,41 Glucose Enhanced solubility 
2 Polysulfide/pluronic30 Glucose Oxidation induced swelling
3 Cyclohexane trisamide-based42 Temperature or pH, and enzyme Gel to solution phase transition
4 4-hydroxymandelic acid based43 Enzyme Enzyme-responsive linkers
5 Disulfide-based triblock copolymer44 Oligopeptide (glutathione) Gel degradation
6 Poly(acrylamide)45 Enzyme Gel dissolution
7 Peptide-based46 Enzyme Matrix degradation
8 Dextran-graft-poly(NIPAm)47 Temperature and enzyme Gel degradation
9 Poly(ethyleneglycol acrylamide)48,49 Enzyme Controlled hydrogel swelling
 Table 1 Recent developments in bioresponsive hydrogels for controlled release.
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drug release; however, the extent of cleavage is limited by the degree 
of crosslinker required to form a suitable gel (Table 1, entry 7). 
Kumashiro et al.47 have proposed a delivery mechanism based upon 
both a temperature range and enzyme activity. The group synthesized 
temperature-responsive hydrogels that only allow enzyme-triggered 
polymer degradation above a lower critical solution temperature and 
below a higher critical solution temperature. They anticipate that this 
technique will allow the release of drug molecules depending on both 
enzyme selectivity and changes in body temperature (Table 1, entry 8).
We have developed a nondissolving, enzyme-responsive hydrogel 
with physically entrapped guest molecules. Macromolecule release is 
determined by charge-induced hydrogel swelling, which is controlled 
enzymatically (Fig. 3, Table 1, entry 9) . A cleavable peptide chain is 
modified to respond to a particular protease. Our studies detail the 
release of 40 kDa dextran and avidin from Asp-Ala-Ala-Arg modified 
gel particles following hydrolysis by thermolysin, a bacterial protease 
(Fig. 3b)48. Previously, we demonstrated that the accessibility of 
poly(ethyleneglycol acrylamide) particles can be controlled by varying 
the extent of charge present. Enzymatic hydrolysis to remove positive 
charge from the hydrogel results in structural collapse, reducting 
molecular accessibility49. This approach may have applications in the 
selective removal of (toxic) macromolecules in biological contexts. 
Future work in this area is likely to focus on further optimization 
of the biocompatibility of polymer systems, their delivery (including 
intracellular delivery), and systems with multiple response modes.
Bioresponsive hydrogels for sensing
Biosensors are an obvious and increasingly important application of 
bioresponsive hydrogels. In these systems, a biological recognition 
event is coupled to a macroscopically observable change in hydrogel 
properties. Specifically in biosensing applications, it is convenient 
that many hydrogels can be readily micro- or nanopatterned to allow 
the development of lab-on-a-chip devices. Hydrogel-based biosensor 
surfaces are frequently based on PEG, which prevents nonspecific 
adsorption of biomolecules. In cell-responsive sensors, this approach 
ensures that the response is governed by the surface chemistry rather 
than an adsorbed protein layer. 
Holtz and Asher50 have developed a hydrogel-based photonic 
crystal that acts as a glucose sensor for patients with diabetes mellitus. 
Glucose oxidase is attached to arrays of polystyrene nanospheres, 
which are then polymerized within a hydrogel matrix. The resulting 
material reversibly swells in the presence of glucose (Table 2, entries 
1, 2) , similar to the glucose-responsive systems described earlier. 
The swelling event increases the mean separation between the 
immobilized nanospheres, shifting the Bragg peak of diffracted light to 
longer wavelengths and producing a red-shift in the optical properties 
(i.e. a readily observed color change) of the polymer (Fig. 4) . This 
system can be implanted as contact lenses or ocular inserts to detect 
small changes in blood glucose levels indirectly via tear fluid. In this 
modified system, boronic acid derivatives are attached to the array and 
polymerized within a network of polyacrylamide-PEG. Glucose binds 
to the derivatives, producing cross-links that shrink the hydrogel and 
cause a blue-shift. The patient is then able to determine their blood 
glucose levels via a color chart (Table 2, entry 1)51-53. 
Another sensor with an optical output signal uses microlenses made 
of poly(N-isopropylacrylamide-co-acrylic acid), or pNIPAm-co-AAc54. 
The pNIPAm-co-AAc microlenses are functionalized with biotin to 
detect avidin and antibiotin antibodies. Binding of these multivalent 
proteins to surface-bound biotin causes additional cross-links to form 
in the gel and increases the local refractive index of the hydrogel. The 
change in optical properties of the gels can be measured qualitatively: 
first by the appearance of ‘dark rings’ in the lenses and second by using 
the lenses to focus a square image; the higher the concentration of 
avidin or antibiotin, the larger the increase in refractive index and the 
more focused the image (Fig. 5; Table 2, entry 2) . 
Kim et al.55 recently reported an example of a whole-cell sensing 
system using interactions between lymphocytes of the immune system. 
Fig. 3 (a) Schematic of enzyme-controlled hydrogel swelling (top). Creation 
of a positively charged gel results in increased bead swelling. The hydrogel is 
loaded by altering the pH and, after neutralization, payload release occurs 
following a specific enzyme reaction (bottom). (b) Charged (avidin) and 
neutral (dextran) macromolecule release profiles in the presence of a cleaving 
and a noncleaving control enzyme. (Adapted and reprinted with permission 
from48. © 2007 Wiley-VCH.)
Entry Stimulus Hydrogel Application Output signal
1 Glucose50-53 PA-PEG Glucose 
biosensor
Optical, color
2 Protein54 pNIPAm-
coAAc
Avidin, 
antibiotin 
biosensor
Optical, 
focusing
3 Peptide55 PEG Live cell 
biosensor
Biochemical, 
fluorescence
4 Enzyme58 Aromatic 
hydrogelator
β-lactamase Gel-formation
Table 2 Recent developments in hydrogel-based 
biosensors.
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PEG hydrogel microwells are functionalized with antibodies that allow 
the specific immobilization of T-cells in a regular pattern at the surface. 
Antigen-capturing B-cells are overlaid on top, and act as receptors 
for target molecules. Upon addition of a solution containing a model 
peptide analyte, B-cells capture and process the peptide molecules, 
presenting them to neighboring T-cells. Receptors on the T-cells 
recognize the presented antigen, causing a biochemical pathway to 
be triggered. Such activation of T-cells can be detected by fluorescent 
monitoring of intracellular Ca levels (Fig. 6; Table 2, entry 3) .
The use of small-molecule hydrogels for enzyme (inhibitor) sensing 
has been demonstrated by Yang et al.10,56,57. Hydrogel formation is 
exploited in the biological sensing of β-lactamases, bacterial enzymes 
that cause antibiotic inactivation in resistant bacterial strains (Table 2, 
entry 4). In this work, treating a nongelling, β-lactam-containing 
conjugate (β-lactam is a substrate for β-lactamases) with β-lactamase 
cleaves the scissile β-lactam amide bond, thereby releasing a potent 
hydrogelator. Gel formation is readily observed by the naked eye. 
This approach provides a low cost and easy to use method that could 
be used to screen for inhibitors of this class of enzymes, which holds 
promise for identification of next generation antibiotics58. 
Bioresponsive hydrogels in tissue engineering
Tissue engineering aims to regenerate damaged or diseased tissues 
and organs59. The development of biomaterials that facilitate the 
mechanical and cellular regeneration of tissue is crucial to its success. 
Current strategies involve the production of porous scaffolds for 
cells to colonize. Ideal scaffolds are those that mimic the ECM that 
surrounds cells in their natural context. The current emphasis is on 
creating materials that are highly hydrated, nanofibrous, directional, 
of appropriate mechanical strength, and contain bioactive signals to 
direct cell behavior23,25,34. Here, we cover recent research on materials 
that respond to (cell-secreted) enzymes or are modified by enzymatic 
action, thereby mimicking the adaptive properties of natural ECMs. 
ECM-mimicking hydrogel scaffolds that permit cell migration have 
been studied by Hubbell and coworkers22,60. The researchers use 
oligopeptides as cross-linkers in PEG-based hydrogels. The peptide 
sequences are cleavable by matrix metalloproteinases (MMPs) to form 
a gel into which cells can infiltrate. MMPs are a family of enzymes 
that have many roles including the breakdown of ECM molecules 
during tissue remodeling and disease. Therefore, the integration of 
MMP-cleavable sites is a logical approach toward ECM mimics. Human 
Fig. 4 (a) Polystyrene particles arrayed within a three-dimensional hydrogel matrix. (b) Upon exposure to an analyte, the array changes in volume, causing a change 
in separation between the particles and a shift in the observed wavelength. (c) Diffraction shifts of up to ~170 nm are observed in response to changes in glucose 
concentration. (Reprinted with permission from52. © 2004 American Association for Clinical Chemistry.)
Fig. 5 (a) Synthesis of pNIPAm-co-AAc hydrogel microparticles by precipitation polymerization, and (b) their biotinylation. Binding of (c) avidin or (d) antibiotin 
causes additional cross-links to be formed in the hydrogel. (e) Formation of dark rings (left column) in different concentrations of avidin and the focusing of a 
square image (right column) in response to avidin binding. (Reprinted with permission from54. © 2005 American Chemical Society.)
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fibroblasts are encouraged to invade the hydrogel through integrin-
binding domains (Arg-Gly-Asp-Ser-Pro) that are incorporated via PEG 
linkers. The fibroblasts then cause a local breakdown of the hydrogel 
cross-links via secreted MMPs (Table 3, entry 1) . The potential for 
bone tissue engineering was tested by loading the gel with bone 
morphogenetic protein-2 (BMP-2), which is known to be involved in 
bone formation. An assessment of the degradation behavior of MMPs 
and the cell invasion of provisional matrices revealed that the healing 
response in vivo depends on the enzymatic sensitivity of the matrix. 
Raeber et al.61 (Table 3, entry 2) subsequently tested the suitability 
of two proteolytically degradable PEG hydrogels as ECM mimics 
that allow regulated cell migration in three dimensions (Fig. 7) . In 
one system, the PEG hydrogel is chemically cross-linked with an 
MMP-sensitive sequence (M-PEG). In the second, a plasmin-sensitive 
sequence (P-PEG) is used. Both sequences have been previously found 
to allow proteolytic remodeling of bone defects. The three-dimensional 
migration patterns and cell morphology of human fibroblasts in 
M-PEG and P-PEG have noticeable differences, with cell migration 
only observed in M-PEG. To regulate the MMP function of the PEG 
hydrogels, two new hydrogels were made, one containing an MMP 
inhibitor and the other an MMP stimulator linked to the PEG hydrogel. 
The former results in complete suppression of cell migration, while the 
latter results in a significant increase in cell migration. These results 
indicate that migration in M-PEG gels is highly sensitive to MMP 
modulation. The ability of a gel to respond to a single class of enzyme 
represents an effective communication between cells and the matrices.
Kim et al.62 have created an injectable hydrogel of pNIPAm-co-AAc 
to mimic the ECM (Table 3, entry 3). These hydrogels are prepared by 
cross-linking an MMP-13/collagenase-3-degradable peptide sequence 
and NIPAm in the presence of Arg-Gly-Asp-modified poly(AAc). The 
proteolytic degradation and cell adhesion properties of this hydrogel 
were studied using rat calvarial osteoblasts. Collagenase was found to 
degrade the hydrogel, with the rate dependent on the concentration 
of collagenase in relation to the poly(AAc) chain. Migration of 
osteoblasts is observed in hydrogels both with and without the Arg-
Gly-Asp peptide. However, greater migration is seen in those hydrogels 
Fig. 6 (a) B-cells capture pathogens, such as the different viral particles shown, and present them as peptide-major histocompatibility complex (p-MHC) 
assemblies. T-cell receptors (TCRs) on T-lymphocytes recognize p-MHCs, causing a signaling pathway response. (b) This interaction is employed in a sensing 
system. (c) The T-cell signaling pathway can be detected by fluorescence. (A) A fluorescence micrograph of microwells immediately after pathogen addition. 
(B) The microwells after 10 min exposure to the pathogen. (Reprinted with permission from55. © 2006 Wiley-VCH.)
Entry Material Stimulus Cell type
1 Oligopeptides
Ac-CGYGRGDSPG60
Metalloproteinase
(MMP)
Human fibroblasts
2 Polyethylene glycol (PEG)61 MMP Dermal fibroblasts
3 pNIPAm-Co-AAc62 MMP-13 Rat calvarial osteoblasts (RCOs)
4 Gelatin/gellan65 TGase Fibroblasts NIH T3 cells
5 Gelatin66 mTGase Retinal tissue
6 Three-dimensional fibrin hydrogels modified with αVβ3 receptor68 TGase Human umbilical cells
7 CH3(CH2)14CO-GTAGLIGQRGDS69 MMP-2 Dental pulp cells
8 Nap-FFGEY70 (i) kinase
(ii) phosphatase
HeLa cells
9 Polyurethane/polycaprolactone/PEG73 Elastase Endothelial cells
10 Phosphoester/PEG72 Alkaline phosphatase Mesenchymal stem cells
 Table 3 Enzyme-responsive gels for tissue regeneration and culture.
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that contain Arg-Gly-Asp. There is also an increase in cell migration 
in MMP-degradable hydrogels compared with nondegradable gels, 
indicating the advantage of bioresponsive hydrogels.
An alternative to man-made polymers is to use natural proteins or 
their by-products. One example is gelatin, which is commonly used 
in biomedical applications. Gelatin is a hydrolyzed form of collagen 
and has been suggested for tissue engineering scaffolds and wound 
dressings. However, cross-linking is essential for these purposes to 
ensure sufficient mechanical strength63. Transglutaminases (TGases) 
are a family of enzymes that catalyze the formation of isopeptide 
bonds between the γ-carboxamide of Gln and a free amine group 
(often from Lys), thereby cross-linking peptide chains64-67. TGase has 
been used as a cross-linking agent for gelatin, making it suitable for 
tissue-engineering applications, such as ophthalmic adhesives and 
scaffolds for tissue reconstruction (Table 3, entries 4 and 5).
Recently, Chen et al.66 produced a biomimetic adhesive based on 
TGase-catalyzed cross-linking of gelatin. This adhesive mimics part of 
the blood coagulation mechanism, the factor XIIIa-mediated cross-
linking of fibrin. This approach improves retinal reattachment during 
eye surgery when compared with currently used materials, such as 
silicone oil. The group also demonstrated that the strength of the 
bond formed is comparable to that of other soft-tissue adhesives. 
This is clearly shown in Fig. 8 , where a cotton swab coated in the 
adhesive is able to pick up bovine retinal tissue. A study into the use 
of gelatin for tissue-engineering scaffolds has been undertaken by 
Bertoni et al.65 (Table 3, entry 4). To improve the long-term stability 
of this system, gelatin is integrated into a polysaccharide, gellan. The 
fibroblast response to the gelatin/gellan hydrogel is better than gelatin 
alone.
In generating new tissue, blood vessels must be formed to provide 
nutrients and dispose of metabolic waste, so the integration of growth 
factors to regulate new blood vessel formation (angiogenesis) is 
pivotal for cell survival. Recently, Hall and Hubbell68 designed a three-
dimensional fibrin hydrogel scaffold that acts as a depot/release system 
for growth factors to aid in angiogenesis (Table 3, entry 6). The fibrin 
matrices are modified by covalently adding receptor binding sites for 
the cell survival integrin αvβ3. The receptor also contains an N-terminal 
recognition site for a TGase. The mechanical stability of the fiber 
structure depends on the receptor concentration, which also activates 
NFκB, a signaling molecule that aids cell survival. In vivo analysis of 
angiogenesis reveals that a denser capillary network forms in receptor-
stimulated matrices than native fibrin networks. Co-stimulation with 
additional growth factors gives similar results to stimulating with either 
the receptor or the growth factors alone. 
One method of combining the advantages of synthetic and natural 
systems is the use of peptide amphiphiles (PAs)4. Jun et al.69 described 
a strategy to regenerate dental tissues using PA molecules that form 
rigid, cell-responsive fibrous nanostructures and incorporate biological 
epitopes (small parts of macromolecules that are recognized by 
antibodies of the immune system) as the peptide part of the molecule 
(Table 3, entry 7). The material is designed to be adhesive to dental 
pulp cells and contain MMP-cleavage sites. At neutral pH, the net 
Fig. 8 (Top) Schematic of eye and retinal reattachment surgery. (Bottom left) Ability of a gelatin-microbial transglutaminase-coated swab to lift retinal tissue. 
(Bottom right) Rat retina 14 days after injection of gelatin solution (A), showing normal histology without damage or cell loss. Rat retina 14 days after injection of 
gelatine + microbial transglutaminase (B). The arrow shows acellular material that represents adhesive deposition or fibrin formation. (Adapted and reprinted with 
permission from66. © 2006 Wiley-VCH.)
Fig. 7 M-PEG gels allow spindle-shaped cell morphologies similar to natural 
fibrin (FIB) and collagen (COL) gels, whereas P-PEG gels inhibit cell spreading. 
(Adapted and reprinted with permission from61. © 2005 Biophysical Society.)
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negative charge on the peptide prevents assembly. Gel formation is 
triggered by the addition of Ca2+ ions, which results in nanostructured 
cylindrical micelles. At high concentrations, physical cross-linking 
occurs. The gels are broken up by adding type IV collagenase, an MMP 
that cleaves the peptide and causes the nanostructure to become 
deformed and more permissive. Pulp cells suspended in a solution prior 
to gelation are found to form dense colonies throughout the gel. 
Enzymatic sol-to-gel transitions have been demonstrated by Yang 
et al.70 using napthyl-pentapeptide, Nap-Phe-Phe-Gly-Glu-Tyr. The 
process reversibly controls self-assembly for in vivo hydrogelation, a 
strategy useful for precise control of cell delivery at the molecular level. 
To regulate the assembly, a pair of enzymes with complementary and 
opposite activities are used: a kinase, which catalyzes the adenosine 
triphosphate (ATP)-driven phosphorylation of Tyr residues; and a 
phosphatase, which catalyzes removal of phosphate groups. Tyrosines 
that carry phosphate groups are negatively charged and prevent self-
assembly by electrostatic repulsion. Dephosphorylation of the tyrosine 
residues by phosphatase triggers hydrogel formation. This system is 
therefore highly dynamic and, with both enzymes present, the level of 
ATP determines the gelation state of the system (Table 3, entry 8). 
We recently demonstrated the use of a protease to produce 
amphiphilic peptide hydrogelators that spontaneously assemble into 
nanofibrous gel structures71,72. This process, termed enzyme-assisted 
self-assembly, forms gelling peptides from nongelling precursors 
in a controlled manner. Since the enzyme reactions proceed under 
thermodynamic control, this method is thought to result in fewer 
defects in the resulting self-assembled structures, thereby inherently 
giving rise to homogeneous gels10. The approach may be used in 
triggered gel-formation in three-dimensional cell culture experiments, 
as demonstrated for similar nonenzymatically gelled systems72. 
A family of enzyme-responsive thermoplastic elastomers containing 
polyurethane, polycaprolactone, and PEG has been developed for soft-
tissue-engineering applications73. These polyurethanes have enzymatic 
remodeling abilities via incorporation of an Ala-Ala-Lys tripeptide that 
is selectively hydrolyzed by elastases. To enhance cell adhesion, the 
peptide Arg-Gly-Asp-Ser is coupled to the hydrogel. Degradation of 
the hydrogels is significantly increased by addition of elastase, and 
endothelial cell adhesion is greater than a plastic tissue culture control 
(Table 3, entry 9).  
A photopolymerized phosphoester-PEG hydrogel has shown 
potential application in bone tissue engineering74. The hydrogel is 
hydrolytically degradable, and the degradation rate increases in the 
presence of a bone-specific enzyme, alkaline phosphatase (Fig. 9; 
Table 3, entry 10) . Goat mesenchymal stem cells secrete bone-specific 
markers, such as osteocalcin and osteonectin, and show alkaline 
phosphatase activity. Gene expression of key markers is promoted 
without addition of growth factors, compared with pure PEG-based 
gels. Calcium deposition in the hydrogels, i.e. mineralization, is also 
observed. 
Since proteases play essential roles in a large number of biological 
processes, including wound healing and cell differentiation, it can be 
expected that enzyme responsiveness will remain an important concept 
in the future. The use of enzymes to trigger self-assembly may provide 
a useful means of generating cell matrices in situ, with new approaches 
being developed to explore a range of enzymes for this purpose70,72.
Conclusion and outlook
The design of bioresponsive materials is a relatively new area but it has 
already demonstrated a range of successful systems for the detection 
of biological compounds, delivery of actives in response to disease-
specific biomolecules, and on-demand presentation of bioactive ligands 
to direct cell behavior and repair tissue. Key areas of future research 
are likely to focus on the understanding and exploitation of molecular 
communication methods found in cell biology for biomaterials design. 
The ultimate aim is to design materials that direct (stem) cell behavior 
in wound healing and tissue regeneration. In order to aid discovery, it 
is likely that further miniaturization will produce hydrogel microarrays 
for massively parallel screening and optimization arrays. These setups 
will help elucidate the space-time requirements of ligand presentation, 
including the use of multiple ligands to induce complex responses. 
Enzyme-triggered presentation of ligands will hold the key to 
precise control of cell fate, with ligands organized with nanoscale 
resolution, as observed in natural ECMs23. This level of control can, in 
principle, be achieved by self-assembly, and future biomaterials can be 
expected to be increasingly constructed using bottom-up approaches. 
Currently, self-assembly is limited to fairly simple structures, usually 
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Fig. 9 (a) Normalized alkaline phosphatase (ALP) content in goat 
mesenchymal stem-cell-encapsulated hydrogels after three weeks of culture 
in osteogenic medium. Final histological phenotype stained with Masson’s 
trichrome for cellular hydrogels (b) and acellular hydrogels (c). Acellular 
controls cultivated in the presence of ALP at 50 units/l in osteogenic medium 
for three weeks are also shown in (c). The three hydrogels are (left) 20% (w/v) 
Phos-PEG gels; (middle) 10% Phos-PEG, 10% PEODA co-gel; and (right) 10% 
PEODA gels. (Adapted and reprinted with permission from71. © 2005 Mary 
Ann Liebert Publishers.)
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composed of one or two different building blocks. Making more 
complex structures is difficult because molecular building blocks may 
get kinetically trapped. Future approaches will focus on overcoming 
kinetic entrapment, which may involve enzyme-assisted assembly 
approaches that are thermodynamically controlled, and the assembly 
of structures one molecule at a time10,72. 
Few of the systems described here are truly dynamic. As with 
all spontaneous processes, under a given set of conditions (pH, 
temperature, pressure) only one direction is thermodynamically 
favored. Nature overcomes this limitation by combining 
thermodynamic and kinetically controlled reactions to obtain 
dynamic systems. Indeed, by combining ATP-dependant kinases and 
phosphatases, dynamic systems have already been produced10,32.
One major limitation of new materials like these is that the 
barriers to use in medical applications are significant. Especially when 
polymeric materials are used, it is essential to determine what 
happens to all the ligands/components once inside the body. Use of 
small-molecule hydrogels may provide a significant advantage, as 
their breakdown profiles are more predictable11. In any case, all new 
hydrogel materials will require extensive testing to gain approval in 
products, which means that it is unlikely that any of these materials 
will be found in the clinic in the near future. However, many of the 
concepts described here are likely to be incorporated in ex vivo 
applications, including three-dimensional cell culture, wound 
dressings, and diagnostic devices, and will increasingly touch our 
everyday lives. 
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